poisar

Stocks · News reference

Outset Medical Q2 Adj. EPS $(0.80) Misses $(0.72) Estimate, Sales $31.635M Beat $29.833M Estimate

Benzinga Newsdesk

Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 4.76 percent increase over losses of $(0.84) per share from

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OM
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

    Fresenius Medical Care is scaling up its 5008X CAREsystem rollout, converting 227 U.S. clinics to the new technology by July 2026, representing 10% of its machine base. The company has performed over 600,000 treatments including 100,000+ high-volume hemodiafiltration treatments, showing clinical promise with 40% fewer muscle cramps. However, near-term headwinds include weak U.S. treatment volume growth (-0.9%), TDAPA reimbursement pressure (€50 million drag expected), and significant rollout implementation costs.

    FMSDVAOM
  2. SEC EDGAR

    8-K filing — Outset Medical, Inc. (OM)

    Filed: 2026-08-28 AccNo: 0001193125-26-374323 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    OM